Filippo Pietrantonio Selected Research

Carcinoma (Carcinomatosis)

11/2023	Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action.
11/2021	Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Filippo Pietrantonio Research Topics

Disease

134	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2010
78	Neoplasms (Cancer) 04/2024 - 09/2011
31	Stomach Neoplasms (Stomach Cancer) 01/2024 - 06/2012
21	Neoplasm Metastasis (Metastasis) 04/2024 - 12/2012
19	Disease Progression 02/2024 - 11/2010
18	Microsatellite Instability 12/2023 - 10/2019
11	Adenocarcinoma 01/2024 - 08/2016
5	Pseudomyxoma Peritonei 12/2023 - 01/2016
5	Colonic Neoplasms (Colon Cancer) 01/2020 - 09/2013
4	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2024 - 01/2022
3	Rectal Neoplasms (Rectal Cancer) 08/2021 - 01/2013
2	Cholangiocarcinoma 12/2023 - 10/2022
2	Carcinoma (Carcinomatosis) 11/2023 - 11/2021
2	Amnesia (Dissociative Amnesia) 01/2023 - 01/2018
2	Esophageal Squamous Cell Carcinoma 01/2023 - 01/2023
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2023 - 05/2014
2	Neutropenia 01/2022 - 01/2021
2	Turcot syndrome 01/2022 - 12/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2011
2	Inflammation (Inflammations) 01/2021 - 01/2020
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2020 - 12/2015
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2019 - 12/2014
1	Diarrhea 01/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2023
1	Gallbladder Neoplasms (Gallbladder Cancer) 12/2023
1	Protein Deficiency 11/2023

Drug/Important Bio-Agent (IBA)

36	Biomarkers (Surrogate Marker)IBA 04/2024 - 03/2012
28	Bevacizumab (Avastin)FDA Link 12/2023 - 02/2011
25	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2020
25	Panitumumab (Vectibix)FDA Link 12/2023 - 12/2013
22	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024 - 01/2010
19	Cetuximab (Erbitux)FDA Link 09/2023 - 12/2013
18	Fluorouracil (Carac)FDA LinkGeneric 01/2024 - 12/2014
17	Irinotecan (Camptosar)FDA LinkGeneric 01/2024 - 06/2012
16	ErbB Receptors (EGF Receptor)IBA 04/2024 - 01/2016
13	Leucovorin (Folinic Acid)FDA Link 01/2024 - 04/2016
11	Capecitabine (Xeloda)FDA Link 12/2023 - 06/2012
10	Monoclonal AntibodiesIBA 01/2023 - 09/2015
9	Temozolomide (Temodar)FDA LinkGeneric 10/2022 - 12/2014
8	regorafenibIBA 02/2024 - 01/2020
7	Circulating Tumor DNAIBA 04/2024 - 12/2019
7	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2013
7	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2014
6	trifluridine tipiracil drug combinationIBA 12/2023 - 11/2017
6	RNA (Ribonucleic Acid)IBA 05/2023 - 01/2018
5	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 04/2016
5	Trastuzumab (Herceptin)FDA Link 06/2023 - 01/2018
5	PlatinumIBA 10/2022 - 01/2013
4	Gemcitabine FDA Link 05/2024 - 11/2010
4	Phosphotransferases (Kinase)IBA 02/2024 - 08/2017
4	atezolizumabIBA 01/2023 - 07/2020
4	avelumabIBA 01/2022 - 10/2021
4	Calcibiotic Root Canal SealerIBA 01/2022 - 01/2016
4	Epidermal Growth Factor (EGF)IBA 01/2022 - 09/2019
4	Docetaxel (Taxotere)FDA Link 04/2021 - 04/2016
3	encorafenibIBA 09/2023 - 01/2020
3	AntibodiesIBA 01/2023 - 01/2016
3	MethyltransferasesIBA 10/2022 - 12/2014
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2018
3	Alkylating AgentsIBA 01/2020 - 12/2014
3	EnzymesIBA 12/2019 - 12/2016
3	afliberceptIBA 11/2018 - 11/2018
2	pembrolizumabIBA 12/2023 - 01/2022
2	LigandsIBA 10/2023 - 09/2013
2	Messenger RNA (mRNA)IBA 10/2023 - 01/2019
2	pertuzumabIBA 01/2023 - 01/2021
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 01/2022
2	Trifluridine (Viroptic)FDA LinkGeneric 05/2020 - 11/2017
2	RamucirumabIBA 03/2019 - 01/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2019 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2017 - 08/2014
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2017 - 11/2010
2	XELOXIBA 12/2014 - 01/2012
1	Circulating MicroRNAIBA 02/2024
1	Tight Junction ProteinsIBA 01/2024
1	folfirinoxIBA 01/2024
1	130-nm albumin-bound paclitaxelIBA 01/2024
1	Metformin (Glucophage)FDA LinkGeneric 12/2023
1	lanreotide (Somatuline)FDA Link 12/2023
1	CholesterolIBA 12/2023
1	sotorasibIBA 12/2023
1	AmphiregulinIBA 10/2023
1	EpiregulinIBA 10/2023

Therapy/Procedure

67	Therapeutics 12/2023 - 02/2011
55	Drug Therapy (Chemotherapy) 05/2024 - 11/2010
7	Immunotherapy 04/2024 - 01/2020
7	Neoadjuvant Therapy 04/2024 - 01/2013
5	Adjuvant Chemotherapy 04/2021 - 04/2014
4	Radiotherapy 11/2023 - 09/2011
4	Hyperthermic Intraperitoneal Chemotherapy 01/2023 - 01/2016
3	Continuity of Patient Care 11/2023 - 12/2016
3	Cytoreduction Surgical Procedures 01/2023 - 01/2016
3	Retreatment 01/2023 - 01/2020
2	Liver Transplantation 01/2023 - 01/2023
2	Hepatectomy 01/2023 - 01/2017
2	Salvage Therapy 05/2020 - 01/2014
2	Precision Medicine 11/2019 - 10/2019